Back

Pfizer in Talks to Acquire Obesity Drug Developer Metzera for $7.3 Billion

The potential deal would expand Pfizer’s presence in the fast-growing market for obesity treatments, according to the Financial Times.

Summary

No Summary provided as the original text is short

Terms & Concepts
  • Acquisition: A corporate action in which one company purchases most or all of another company's shares to gain control of it.
  • Obesity Treatment: Therapies or medications aimed at reducing body weight and managing obesity-related health conditions.